none

NEW LASER HQ PROVIDES TIGHT FOCUS

29-01-2018
by 
in 
Ellex Executive Director Dr Meera Verma at the company’s new headquarters.

Ellex is a global leader in medical devices for the diagnosis and treatment of eye disease, and its new 2.18 hectare facility in the northern suburb of Mawson Lakes allows its machine shop, clean rooms and administration to be co-located for the first time.

A major feature of the new headquarters is the Controlled Environment Room (CER), which is a state of the art, dust free space where the lasers are built to eliminate any risk of contamination.

Early indications have already shown measurable reductions in costs and manufacturing time per unit, without any risk of compromising the quality and reliability of products.

Ellex already sells its laser and ultrasound systems in more than 100 countries and has offices in the United States, France, Germany and Japan. It operates across five areas of eye health: glaucoma; diabetic eye diseases; secondary cataracts; age-related macular degeneration; and, vitreous opacities, which are commonly know as eye floaters.

Executive Director Dr Meera Verma said Ellex almost doubled the laser and ultrasound side of the business between 2013 and 2017 and was experiencing remarkable growth – from 10,000 units to 50,000 units a year – with its illuminated, micron-scale microcatheter iTrack.

“The largest area we have an opportunity to expand into is glaucoma because we’ve got unique combination of products – we’re about the only company in the world that has a laser and a catheter to treat glaucoma,” Dr Verma said.

“The new facility positions us well and has given us the capacity to grow and explore a number of other opportunities on the global stage... We also have co-located our machine shop, which really improves the input of our machine shop into what we do, it allows us to actually consider swapping out imported parts for locally produced components and that has huge potential for assisting our profitability as well as our market reach.”

Dr Verma said while products for the treatment of glaucoma were the company’s biggest seller, there was a significant opportunity for growth in the area of age-related macular degeneration, and Ellex is developing a new product that is due to finish a three-year clinical trial in 2018.

“It’s a very gentle laser and it help rejuvenate cells in the retina that have been affected by macular degeneration to help people recover their sight and stop it from getting any worse," she said.

Related news & editorials

  1. 19.03.2019
    19.03.2019
    by      In
    Newmont Mining Corporation’s Tanami Power Project has been completed safely and on schedule. The project, in the west of the Northern Territory, included the installation of two power stations, a 66kV interconnected power line and a 450km natural gas pipeline. The pipeline was built and will be... Read More
  2. 19.03.2019
    19.03.2019
    by      In
    Corio Bay Dairy Group (CBDG) is a joint venture between 100 per cent Australian farmer owned Organic Dairy Farmers of Australia (ODFA), Wattle Health Australia, and Blend and Pack.
    CBDG has commenced earthworks at Cowie St, North Geelong, building Australia’s first dedicated organic nutritional... Read More
  3. 15.03.2019
    15.03.2019
    by      In
    Flushed with success, Australian master distributor Control Logic took out all three awards from the prestigious Emerson Machine Automation Solutions 2019 Asia Channel meeting held in Shanghai. This was the company’s second consecutive successful year at the prestigious meeting, and included the “... Read More
  4. 15.03.2019
    15.03.2019
    by      In
    A circular economy represents a golden opportunity to combine corporate sustainability with profits, but is obstructed by weak chemicals legislations in every part of the world. In many cases, the corporate world is ahead of legislation, and the notion that there is a contradiction between... Read More